NYSE$NGVT
Ingevity Corporation · Q2 2021 earnings
Q2 2021 earnings · · Investor relations
Briefing
Ingevity's second quarter performance was driven by increased volumes and price increases across segments, leading to significant growth in net sales, net income, and adjusted EBITDA.
Ingevity reported strong second quarter results with net sales up 32.4% to $358.4 million and net income up 119.3% to $44.3 million. Adjusted EBITDA increased by 75.1% to $117.7 million. The company also increased its full year 2021 guidance for sales and adjusted EBITDA.
- Net sales increased by 32.4% to $358.4 million.
- Net income rose 119.3% to $44.3 million, with a net income margin of 12.4%.
- Adjusted EBITDA increased 75.1% to $117.7 million, with an adjusted EBITDA margin of 32.8%.
- Free cash flow was up 23.6% to $41.9 million.
Headline financials
Revenue & EPS history
Ingevity · Revenue · Quarterly
$358M
Revenue by segment
Ingevity · $358M total across 2 segments · Q2 2021
- Performance Chemicals$232M+24.8%64.8%
- Performance Materials$126M+49.3%35.2%
Forward guidance
Ingevity has increased its full year 2021 guidance from sales between $1.275 billion and $1.325 billion to sales between $1.320 billion to $1.360 billion, and from adjusted EBITDA between $410 million and $430 million to adjusted EBITDA between $425 million to $440 million.
Tailwinds
- Solid performance in the first half of the year
- Continued robust demand for our products
- Team’s ability to deliver strong performance in the second half of the year
- Sales between $1.320 billion to $1.360 billion
- Adjusted EBITDA between $425 million to $440 million
Headwinds
- Ongoing transportation and logistics headwinds
- Raw materials inflation
- Automotive sector input disruptions
- Microchip shortage continues to impact automotive production on a global scale.
- China light vehicle production declined 4.9% versus the prior year quarter
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2021
+1.9%
Avg return
Earnings day
+1.9%
Avg return
5 days after
+2.2%
Avg return
30 days after
58%
26 / 45 earnings
Positive
+22.0%
Q1 2020
Best reaction
-15.8%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -4.9% | -8.2% | -15.3% | |
| Q4 2025 | +0.3% | +1.5% | +1.4% | |
| Q3 2025 | -15.8% | -9.1% | -2.8% | |
| Q1 2025 | +0.9% | +9.8% | +7.3% | |
| Q4 2024 | +5.3% | +0.6% | -7.5% | |
| Q3 2024 | +16.5% | +17.5% | +33.5% | |
| Q2 2024 | -7.5% | -23.2% | -14.3% | |
| Q1 2024 | +7.2% | +5.3% | -4.5% | |
| Q4 2023 | +3.1% | +4.7% | +3.1% | |
| Q3 2023 | +5.0% | -0.5% | +1.1% | |
| Q2 2023 | -11.2% | -14.0% | -12.4% | |
| Q1 2023 | -8.4% | -15.9% | -26.3% | |
| Q4 2022 | -6.8% | -7.8% | -21.1% | |
| Q3 2022 | +3.6% | +8.2% | +14.1% | |
| Q2 2022 | +5.0% | +3.0% | +4.2% | |
| Q1 2022 | +9.6% | +9.2% | +19.7% | |
| Q4 2021 | +0.9% | +4.2% | -0.5% | |
| Q3 2021 | -0.6% | -0.5% | -5.6% | |
| Q2 2021 | +5.4% | +1.4% | -1.0% | |
| Q1 2021 | +4.6% | +10.2% | +10.4% | |
| Q4 2020 | -6.6% | -4.6% | +6.3% | |
| Q3 2020 | -1.4% | +0.1% | +8.9% | |
| Q2 2020 | -2.1% | +1.9% | +1.3% | |
| Q1 2020 | +22.0% | +12.2% | +23.8% | |
| Q4 2019 | -2.9% | +2.5% | -24.5% | |
| Q3 2019 | +1.7% | +2.8% | +4.6% | |
| Q2 2019 | -1.2% | -2.9% | -26.9% | |
| Q1 2019 | -10.9% | -9.8% | -23.7% | |
| Q4 2018 | +9.8% | +13.2% | +3.0% | |
| Q3 2018 | +2.3% | -0.6% | +9.8% | |
| Q2 2018 | +11.3% | +10.0% | +14.5% | |
| Q1 2018 | +2.4% | +2.7% | -0.2% | |
| Q4 2017 | +7.3% | +12.3% | +3.8% | |
| Q3 2017 | +2.2% | +5.8% | +11.0% | |
| Q2 2017 | -0.7% | +1.3% | +8.1% | |
| Q1 2017 | -6.5% | -7.2% | -5.4% | |
| Q4 2014 | +4.3% | +2.5% | +6.7% | |
| Q4 2016 | -4.6% | -6.8% | +7.0% | |
| Q3 2015 | +11.0% | +10.8% | +22.7% | |
| Q3 2016 | +7.2% | +8.3% | +21.1% | |
| Q2 2015 | +14.3% | +14.8% | +17.2% | |
| Q2 2016 | +15.8% | +15.8% | +18.4% | |
| Q1 2016 | -0.3% | — | — | |
| Q1 2015 | -0.3% | — | — | |
| Q4 2015 | -0.3% | — | — | |
| Q3 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q1 2014 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro